146 related articles for article (PubMed ID: 38423021)
21. Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers.
Babayigit C; Ozer B; Ozer C; Inandi T; Duran N; Gocmen O
Med Sci Monit; 2014 Mar; 20():521-9. PubMed ID: 24681806
[TBL] [Abstract][Full Text] [Related]
22. Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates.
Chan PC; Yang CH; Chang LY; Wang KF; Kuo YC; Lin CJ; Lee SW; Hsueh PR; Fang CT; Huang LM
Thorax; 2013 Mar; 68(3):263-8. PubMed ID: 23019256
[TBL] [Abstract][Full Text] [Related]
23. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers.
Harada N; Nakajima Y; Higuchi K; Sekiya Y; Rothel J; Mori T
Infect Control Hosp Epidemiol; 2006 May; 27(5):442-8. PubMed ID: 16671023
[TBL] [Abstract][Full Text] [Related]
24. [Friend or Foe? Evaluation of BCG Vaccine and Latent Tuberculosis Infection Effect in Patients Diagnosed with COVID-19 Infection].
Erdem HA; Şanlıdağ G; Çınar E; Yaşar M; Pullukçu H; Taşbakan MS; Çavuşoğlu C; Gökengin D; Işıkgöz Taşbakan M
Mikrobiyol Bul; 2021 Jul; 55(3):300-310. PubMed ID: 34416798
[TBL] [Abstract][Full Text] [Related]
25. Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
Spertini F; Audran R; Chakour R; Karoui O; Steiner-Monard V; Thierry AC; Mayor CE; Rettby N; Jaton K; Vallotton L; Lazor-Blanchet C; Doce J; Puentes E; Marinova D; Aguilo N; Martin C
Lancet Respir Med; 2015 Dec; 3(12):953-62. PubMed ID: 26598141
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON(®)-TB Gold (+) Kenyan adults without evidence of tuberculosis.
Walsh DS; Owira V; Polhemus M; Otieno L; Andagalu B; Ogutu B; Waitumbi J; Hawkridge A; Shepherd B; Pau MG; Sadoff J; Douoguih M; McClain JB;
Vaccine; 2016 May; 34(21):2430-2436. PubMed ID: 27026148
[TBL] [Abstract][Full Text] [Related]
27. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
28. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection.
Vinton P; Mihrshahi S; Johnson P; Jenkin GA; Jolley D; Biggs BA
Infect Control Hosp Epidemiol; 2009 Mar; 30(3):215-21. PubMed ID: 19191484
[TBL] [Abstract][Full Text] [Related]
29. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.
Diel R; Nienhaus A; Lange C; Meywald-Walter K; Forssbohm M; Schaberg T
Respir Res; 2006 May; 7(1):77. PubMed ID: 16707012
[TBL] [Abstract][Full Text] [Related]
30. Screening for tuberculosis infection in spanish healthcare workers: Comparison of the QuantiFERON-TB gold in-tube test with the tuberculin skin test.
Alvarez-León EE; Espinosa-Vega E; Santana-Rodríguez E; Molina-Cabrillana JM; Pérez-Arellano JL; Caminero JA; Serrano-Aguilar P
Infect Control Hosp Epidemiol; 2009 Sep; 30(9):876-83. PubMed ID: 19614541
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
[TBL] [Abstract][Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
33. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
[TBL] [Abstract][Full Text] [Related]
34. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
35. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test.
Soborg B; Andersen AB; Larsen HK; Weldingh K; Andersen P; Kofoed K; Ravn P
Scand J Infect Dis; 2007; 39(6-7):554-9. PubMed ID: 17577817
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
Tameris MD; Hatherill M; Landry BS; Scriba TJ; Snowden MA; Lockhart S; Shea JE; McClain JB; Hussey GD; Hanekom WA; Mahomed H; McShane H;
Lancet; 2013 Mar; 381(9871):1021-8. PubMed ID: 23391465
[TBL] [Abstract][Full Text] [Related]
37. Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
Pittet LF; Messina NL; Orsini F; Moore CL; Abruzzo V; Barry S; Bonnici R; Bonten M; Campbell J; Croda J; Dalcolmo M; Gardiner K; Gell G; Germano S; Gomes-Silva A; Goodall C; Gwee A; Jamieson T; Jardim B; Kollmann TR; Lacerda MVG; Lee KJ; Lucas M; Lynn DJ; Manning L; Marshall HS; McDonald E; Munns CF; Nicholson S; O'Connell A; de Oliveira RD; Perlen S; Perrett KP; Prat-Aymerich C; Richmond PC; Rodriguez-Baño J; Dos Santos G; da Silva PV; Teo JW; Villanueva P; Warris A; Wood NJ; Davidson A; Curtis N;
N Engl J Med; 2023 Apr; 388(17):1582-1596. PubMed ID: 37099341
[TBL] [Abstract][Full Text] [Related]
38. Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).
Gudjónsdóttir MJ; Kötz K; Nielsen RS; Wilmar P; Olausson S; Wallmyr D; Trollfors B
BMC Infect Dis; 2016 Oct; 16(1):540. PubMed ID: 27716176
[TBL] [Abstract][Full Text] [Related]
39. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.
Martinez L; Cords O; Liu Q; Acuna-Villaorduna C; Bonnet M; Fox GJ; Carvalho ACC; Chan PC; Croda J; Hill PC; Lopez-Varela E; Donkor S; Fielding K; Graham SM; Espinal MA; Kampmann B; Reingold A; Huerga H; Villalba JA; Grandjean L; Sotgiu G; Egere U; Singh S; Zhu L; Lienhardt C; Denholm JT; Seddon JA; Whalen CC; García-Basteiro AL; Triasih R; Chen C; Singh J; Huang LM; Sharma S; Hannoun D; Del Corral H; Mandalakas AM; Malone LL; Ling DL; Kritski A; Stein CM; Vashishtha R; Boulahbal F; Fang CT; Boom WH; Netto EM; Lemos AC; Hesseling AC; Kay A; Jones-López EC; Horsburgh CR; Lange C; Andrews JR
Lancet Glob Health; 2022 Sep; 10(9):e1307-e1316. PubMed ID: 35961354
[TBL] [Abstract][Full Text] [Related]
40. Latent tuberculosis infection among health-care workers using Quantiferon-TB Gold-Plus in a country with a low burden for tuberculosis: prevalence and risk factors.
Almohaya A; Aldrees A; Akkielah L; Hashim AT; Almajid F; Binmoammar T; Barry MA
Ann Saudi Med; 2020; 40(3):191-199. PubMed ID: 32493098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
